Comprehensive validation of published immunohistochemical prognostic biomarkers of prostate cancer—what has gone wrong? A blueprint for the way forward in biomarker studies-Reference-Cited by-同舟云学术

Comprehensive validation of published immunohistochemical prognostic biomarkers of prostate cancer—what has gone wrong? A blueprint for the way forward in biomarker studies

Published:2014-11-25 Issue:1 Volume:112 Page:140-148
ISSN:0007-0920
Container-title:British Journal of Cancer
language:en
Short-container-title:Br J Cancer

Author:

Huber F,Montani M,Sulser T,Jaggi R,Wild P,Moch H,Gevensleben H,Schmid M,Wyder S,Kristiansen G

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://www.nature.com/articles/bjc2014588.pdf

Reference30 articles.

1. Altman DG (1998) Suboptimal analysis using 'optimal' cutpoints. Br J Cancer 78 (4): 556–557.

2. Altman DG, Lausen B, Sauerbrei W, Schumacher M (1994) Dangers of using "optimal" cutpoints in the evaluation of prognostic factors. J Natl Cancer Inst 86 (11): 829–835.

3. Attard G, Clark J, Ambroisine L, Fisher G, Kovacs G, Flohr P, Berney D, Foster CS, Fletcher A, Gerald WL, Moller H, Reuter V, De Bono JS, Scardino P, Cuzick J, Cooper CS (2008) Duplication of the fusion of TMPRSS2 to ERG sequences identifies fatal human prostate cancer. Oncogene 27 (3): 253–263.

4. Attard G, de Bono JS (2009) Prostate cancer: PSA as an intermediate end point in clinical trials. Nat Rev Urol 6 (9): 473–475.

5. Beer M, Montani M, Gerhardt J, Wild PJ, Hany TF, Hermanns T, Muntener M, Kristiansen G (2012) Profiling gastrin-releasing peptide receptor in prostate tissues: clinical implications and molecular correlates. Prostate 72 (3): 318–325.

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A tumour‐associated macrophage‐based signature for deciphering prognosis and immunotherapy response in prostate cancer;IET Systems Biology;2024-08-13

2. Evaluation of the Immunohistochemical Scoring System of CDX2 Expression as a Prognostic Biomarker in Colon Cancer;Diagnostics;2024-05-15

3. Clinical implications of AGR2 in primary prostate cancer: Results from a large‐scale study;APMIS;2024-01-30

4. Development of a novel, clinically relevant anoikis-related gene signature to forecast prognosis in patients with prostate cancer;Frontiers in Genetics;2023-08-30

5. Critical Evaluation of Transcripts and Long Noncoding RNA Expression Levels in Prostate Cancer Following Radical Prostatectomy;Pathobiology;2023-07-18